Company / Current Liabilities per Share
Outlook Therapeutics, Inc. Current Liabilities per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$1.92
FY2025
5-year range
$0.56 / $2.25
FY2021-FY2025
Trend
+245.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Liabilities per Share changed +245% YoY in FY2025, a notable deviation from the 5-year average annual change of +41%.
Based on SEC 10-K filings.
1.92 in FY2025 with a 5-year CAGR of +28.1%.
Improved from $2.25 to $1.92 over the past 6 years.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- +28.1%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, current liabilities per share increased 245.1% year-over-year.
- Peak current liabilities per share was recorded in FY2019.
- Lowest current liabilities per share in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -13.34 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.92 | +245.1% |
| FY2020 | $0.56 | -75.3% |
| FY2019 | $2.25 | +74.9% |
| FY2018 | $1.29 | +2.0% |
| FY2017 | $1.26 | -41.8% |
| FY2016 | $2.17 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026